Longevity to a sirtuin extent

SIRTLab’s Professor Haim Cohen on SIRT6 and its importance in longevity research.

Not many companies style themselves as longevity-focused, but SIRTLab Corporation, a US Company with research laboratories in the Weizmann Science Park, Israel, is one that is very happy to do so. With a patented suite of advanced technologies to raise the specific and direct activity of the SIRT6 protein, SIRTLab has various age-related diseases in its sights, including liver disease, frailty, metabolic syndrome, neurodegeneration and inflammatory conditions.

My take on this: Boasting leading geroscience researcher Dr Nir Barzilai as its Chief Medical Adviser, SIRTLab was founded by Boaz Misholi and Professor Haim Cohen, a world leader in research of SIRT6, who has seen over $40 million invested in his research. We caught up with Cohen to find out more about SIRT6 and the role of sirtuins in longevity.

Haim Cohen on the importance of SIRT6

In longevity terms, I would say SIRT6 is the main regulator of healthy lifespan and the main regulator of longevity, We found that SIRT6 levels increase due to caloric restriction, and to explore whether SIRT6 mediates the effect of caloric restriction, we generated mice that over-expressed SIRT6 and found those mice lived, on average, 30% longer than average mice and had a long list of positive phenotype effects that extended healthy lifespan.

Watch Haim Cohen's in-depth discussion on SIRT6, its role in longevity and the upcoming strides for SIRTLab HERE.

Thank you for reading! If you enjoyed this article, it would mean a lot to me if you could subscribe and share it on LinkedIn!